Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
Biological Chemistry|August 10, 2011
Septin9 is involved in septin filament formation and cellular stabilityAnnette Füchtbauer, Louise B Lassen, Astrid B Jensen, et al.Genes & Development|June 1, 2013
Gsx2 controls region-specific activation of neural stem cells and injury-induced neurogenesis in the adult subventricular zoneAlejandro López-Juárez, Jennifer Howard, Kristy Ullom, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 25, 2023
Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023Esther Kissling, Marine Maurel, Hanne-Dorthe Emborg, et al.Infection and Immunity|July 15, 2015
Phosphoantigen Burst upon Plasmodium falciparum Schizont Rupture Can Distantly Activate Vγ9Vδ2 T CellsMarianne Guenot, Séverine Loizon, Jennifer Howard, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2021
Radiation-Induced Macrophage Senescence Impairs Resolution Programs and Drives Cardiovascular InflammationSudeshna Sadhu, Christa Decker, Brian E Sansbury, et al.The Journal of Infectious Diseases|April 4, 2017
The Antigen-Presenting Potential of Vγ9Vδ2 T Cells During Plasmodium falciparum Blood-Stage InfectionJennifer Howard, Séverine Loizon, Christopher J Tyler, et al.Vaccine|January 28, 2019
Chronic helminth infection does not impair immune response to malaria transmission blocking vaccine Pfs230D1-EPA/Alhydrogel® in miceCamila H Coelho, Pedro Henrique Gazzinelli-Guimaraes, Jennifer Howard, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2019
Cutting Edge: Core Binding Factor β Is Required for Group 2 Innate Lymphoid Cell ActivationXiaofei Shen, Mingwei Liang, Xiangyu Chen, et al.Nature Communications|November 19, 2025
Advancing interdisciplinary science of gender is key to the success of blue carbon initiativesWhitney Yadao-Evans, Diana E Lopez, Lalao Aigrette, et al.The Lancet Regional Health. Europe|December 27, 2024
COVID-19 vaccine effectiveness against SARS-CoV-2-confirmed hospitalisation in the eastern part of the WHO European Region (2022-2023): a test-negative case-control study from the EuroSAVE networkMark A Katz, Sandra Cohuet, Silvia Bino, et al.Pageof 7